Similar Search Results

Bürgerversicherung - Die Wirkung von Kopfprämien auf den Arbeitsmarkt

Farhauer, Oliver; Borchardt, Katja; Stargardt, Tom - In: Zeitschrift für die gesamte Versicherungswissenschaft … 93 (2004) 3, pp. 349-371

Persistent link: https://www.econbiz.de/10002402025

Bürgerversicherung : die Wirkung von Kopfprämien auf den Arbeitsmarkt

Farhauer, Oliver; Borchardt, Katja; Stargardt, Tom - 2004

Persistent link: https://www.econbiz.de/10002023434

Determining the 'Health Benefit Basket' of the Statutory Health Insurance Scheme in Germany : Methodologies and Criteria

Busse, Reinhard - 2010

The issue of defining health benefit catalogues has recently gained new importance in Germany as a result of the creation of the new Institute for Quality and Efficiency. The Institute was designed to support the Federal Joint Committee conducting effectiveness studies for benefit coverage...

Persistent link: https://www.econbiz.de/10013146562

Der Preis des Rauchens : Eine Analyse für Deutschland

Homann, Reimund - 2017

Persistent link: https://www.econbiz.de/10012792829

Reimbursement of pharmaceuticals : reference pricing versus health technology assessment

Drummond, Michael F.; Jönsson, Bengt; Rutten, F. F. H.; … - In: The European journal of health economics : HEPAC ; … 12 (2011) 3, pp. 263-271

Persistent link: https://www.econbiz.de/10009124305

The impact of physician-level drug budgets on prescribing behavior

Blankart, Katharina; Koch, Taika; Kostev, Karel; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 213-222

Persistent link: https://www.econbiz.de/10011946212

Preferred supplier contracts in post-patent prescription drug markets

Blankart, Rudolf; Stargardt, Tom - In: Health care management science 20 (2017) 3, pp. 419-432

Persistent link: https://www.econbiz.de/10011741304

Do discontinuities in marginal reimbursement affect inpatient psychiatric care in Germany?

Pott, Clara; Stargardt, Tom; Schneider, Udo; Frey, Simon - In: The European journal of health economics 22 (2021) 1, pp. 101-114

Persistent link: https://www.econbiz.de/10012433956

The diffusion of generics after patent expiry in Germany

Blankart, Katharina; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 17 (2016) 8, pp. 1027-1040

Persistent link: https://www.econbiz.de/10011660160

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data

Frey, Simon; Linder, Roland; Juckel, Georg; Stargardt, Tom - In: The European Journal of Health Economics 15 (2014) 2, pp. 133-142

We use longitudinal patient-level data from a German sickness fund with 7.26 million insured in a Markov-simulation model to assess the cost-effectiveness of long-acting injectable risperidone (LAI-RIS) compared with long-acting injectable flupentixol (LAI-FLX) in the long-term management of...

Persistent link: https://www.econbiz.de/10010993904